NCT06641414
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06641414
Title Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).
Acronym GLORA-4
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Ascentage Pharma Group Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
MD Anderson Cancer Center RECRUITING Houston Texas 77054 United States Details
Peking University People's Hospital RECRUITING Beijing Beijing Municipality 100033 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field